Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

10.75
Delayed Data
As of Mar 24
 -0.11 / -1.01%
Today’s Change
10.35
Today|||52-Week Range
38.50
-25.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
AssetsCash1.3B852.4M658.5M542.0M
 
 
 
 
 
Short Term Investment Cash713.1M-449.8M-201.1M-116.9M
 
 
 
 
 
Cash & Short Term Investments1.3B853.4M659.5M543.0M
 
 
 
 
 
 
ReceivablesReceivables2.7B2.7B2.7B2.5B
 
 
 
 
 
 
InventoriesInventories1.3B1.3B1.3B1.1B
 
 
 
 
 
 
Current AssetsPrepaid Expenses------8.0M
 
 
Other Current Assets894.4M895.8M1.0B948.0M
 
 
 
 
 
Current Assets6.2B5.8B5.7B5.1B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross------2.5B
 
 
Depreciation-------1.2B
 
 
Intangible Assets40.9B39.8B38.0B34.7B
 
 
 
 
 
Other Assets41.2B40.1B38.2B37.0B
 
 
 
 
 
Total Assets49.0B47.7B45.8B43.5B
 
 
 
 
 
 
LiabilitiesAccounts Payable438.1M425.9M358.7M324.0M
 
 
 
 
 
Short Term Debt675.1M294.1M59.0M7.0M
 
 
 
 
 
Accrued Expenses3.3B3.3B3.4B12.0M
 
 
 
 
 
Other Current Liabilities3.5B3.5B3.5B2.9B
 
 
 
 
 
Other Liabilities4.6B4.2B3.9B3.6B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt31.3B30.8B30.4B29.8B
 
 
 
 
 
Deferred Taxes-5.7B-5.6B-5.4B-5.3B
 
 
 
 
 
Other Liabilities1.1B1.1B1.1B1.0B
 
 
 
 
 
Total Liabilities43.2B42.3B41.5B40.3B
 
 
 
 
 
 
EquityMinority Interest-800.0K-1.7M-700.0K-3.0M
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity5.7B5.3B4.2B3.2B
 
 
 
 
 
Total Shareholder Equity5.7B5.3B4.2B3.2B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding343.0M343.0M347.7M347.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.